NIH

World, Meet NIH's Kizzmekia Corbett: Leader of Clinical Trial in Search of Coronavirus Vaccine

The National Institute of Health's Kizzmekia Corbett is the leader of the clinical trial in search of a vaccine for coronavirus. This young woman is praised by her superiors and is deemed as the "best fit" for the job. The first stages of the clinical trials started early in March and many are counting on her and her team to quickly come up with a cure to fight the pandemic. How does she handle all the stress? Click the link above to find out.
The Bill & Milinda Gates Foundation Collaborates with Private Companies to Fight Coronavirus with the COVID-19 Therapeutics Accelerator

A Better Approach to Coronavirus Vaccine Plausible? Synthetic Biologists Think So

Regardless of the companies' initiative to rush in developing and testing vaccines that fight the new Coronavirus (COVID-19), the Bill and Melinda Gates Foundation, as well as the National Institutes of Health, bet that scientists, particularly the synthetic biologists, "can do even better than what's currently in the pipeline."

Your Cup of Joe Could Prevent Skin Cancer

According to new research from Yale University and the National Cancer Institute at the National Institutes of Health (NIH), drinking coffee everyday could reduce your for malignant melanoma skin cancer.

Recommended Stories

Real Time Analytics